Content
09/09/2024
Lexington, MA USA
CSA Medical
completed $53 million Series D Round funding. Investors include
TVM Capital Life Science (lead), Yonjin Venture (lead), Ascension Ventures, Blue Heron Capital, First Analysis, Intersouth Partners, SV Health Investors.
About
CSA Medical, Inc. develops and manufactures the RejuvenAir System, a proprietary interventional liquid nitrogen spray cryotherapy system that utilizes software-driven dosimetry and specialty catheters to enable delivery of cryogen spray inside the airways to flash freeze and destroy damaged cells allowing for a rejuvenative pattern of healing. The RejuvenAir System is approved in the EU and under clinical investigation in the United States.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
